Literature DB >> 14935322

The treatment of Sjögren's syndrome with ACTH.

E F B CADMAN, A J ROBERTSON.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; SJOEGREN SYNDROME

Mesh:

Substances:

Year:  1952        PMID: 14935322      PMCID: PMC2021257          DOI: 10.1136/bmj.2.4775.68

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  SJOGREN'S SYNDROME, ESPECIALLY ITS NON-OCULAR FEATURES.

Authors:  F P Weber
Journal:  Br J Ophthalmol       Date:  1945-06       Impact factor: 4.638

2.  Mikulicz's disease.

Authors:  T G HEATON; E H SHANNON
Journal:  Can Med Assoc J       Date:  1948-04       Impact factor: 8.262

3.  Sjögren's disease, with dryness of the bronchial mucosa and uncertain lung lesion.

Authors:  P ELLMAN; F P WEBER
Journal:  Br Med J       Date:  1949-02-19

4.  Early clinical results of ACTH and cortisone treatment of ocular diseases.

Authors:  J R FITZGERALD; J G BELLOWS; J M DONEGAN; R C GAMBLE; A C KRAUSE; W A MANN; M D PEARLMAN; T N ZEKMAN
Journal:  AMA Arch Ophthalmol       Date:  1951-03

5.  Keratoconjunctivitis sicca; a review with a survey of 121 additional cases.

Authors:  J W HENDERSON
Journal:  Am J Ophthalmol       Date:  1950-02       Impact factor: 5.258

  5 in total
  5 in total

1.  Kerato-conjunctivitis sicca treated with cortisone and ACTH.

Authors:  S EADIE; M THOMPSON
Journal:  Br J Ophthalmol       Date:  1955-02       Impact factor: 4.638

2.  Sjögren's syndrome and systemic lupus erythematosus.

Authors:  J M HEATON
Journal:  Br Med J       Date:  1959-02-21

3.  [Steroid excretion in Sjögren syndrome].

Authors:  J G RAUSCH-STROOMAN; H DORKEN
Journal:  Klin Wochenschr       Date:  1956-03-01

4.  Sjögren's syndrome treated with ACTH.

Authors:  K J GURLING; R S BRUCE-PEARSON; M H POND
Journal:  Br J Ophthalmol       Date:  1954-10       Impact factor: 4.638

5.  BENIGN LYMPHOEPITHELIAL SALIVARY LESION TO BE DISTINGUISHED FROM ADENOLYMPHOMA.

Authors:  A H CRUICKSHANK
Journal:  J Clin Pathol       Date:  1965-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.